Skip to main content

Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials.

Publication ,  Journal Article
Hakeem, A; Khan, FM; Bhatti, S; Samad, Z; Effat, MA; Eckman, MH; Helmy, T
Published in: J Invasive Cardiol
November 2009

BACKGROUND: To assess the optimal percutaneous coronary intervention (PCI) approach for coronary artery bifurcation lesions (CBL), we conducted a meta-analysis of randomized trials comparing provisional stenting (PS) to complex stenting strategy (CS). DATA SOURCES: PubMed, Cochrane Register of Controlled Trials, conference proceedings, and internet-based resources of clinical trials. DATA SYNTHESIS: Six randomized trials comparing the PS to the CS approach for CBL with a total of 1,641 patients met the selection criteria for meta-analysis. There was no difference in the clinical profile between the two groups. No significant heterogeneity was found across trials. There was no difference in the reference vessel diameter of the main vessel (MV) (2.73 +/- 0.41 CS; 2.7 +/- 0.44 PS; p = 0.77) and side branch (SB) (2.31 +/- 0.33 CS; 2.27 +/- 0.34 PS; p = 0.30).There was no difference in the primary clinical outcome of major adverse cardiovascular events (MACE) between the two approaches (12.6% vs. 9.6%; relative risk [RR] 1.23, 95% CI, 0.91-1.68; p = 0.18). Similarly, no differences in other clinical endpoints including death (1% vs. 1.1%, RR 0.93, 95% CI, 0.37-;2.33; p = 0.87), target lesion revascularization (TLR) (6% vs. 5.3%, RR 1.10, 95% CI, 0.73-1.64; p = 0.66), stent thrombosis (ST) (1.8% vs. 0.8%, RR 1.60, 95% CI, 0.65-3.91; p = 0.30), MV restenosis (4.9% vs. 5%; RR 0.74, 95% CI, 0.40-1.38; p = 0.34) and SB restenosis (13.8% vs. 13.8%; RR 1.00, 95% CI, 0.65-1.54); p = 0.99] were observed at a mean follow up of 10 months and a mean angiographic follow up of 7 months. Myocardial infarction (MI) was, however, significantly higher in the CS vs. the PS group (6.8% vs. 3.6%, RR 1.71, 95% CI, 1.02-2.88; p = 0.04). CONCLUSION: A CS strategy for CBL had a significantly higher risk of MI compared to a PS strategy. Rates of death, ST, restenosis and TLR were similar.

Duke Scholars

Published In

J Invasive Cardiol

EISSN

1557-2501

Publication Date

November 2009

Volume

21

Issue

11

Start / End Page

589 / 595

Location

United States

Related Subject Headings

  • Stents
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Myocardial Infarction
  • Incidence
  • Humans
  • Coronary Restenosis
  • Coronary Artery Disease
  • Cardiovascular System & Hematology
  • Angioplasty, Balloon, Coronary
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hakeem, A., Khan, F. M., Bhatti, S., Samad, Z., Effat, M. A., Eckman, M. H., & Helmy, T. (2009). Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials. J Invasive Cardiol, 21(11), 589–595.
Hakeem, Abdul, Faisal M. Khan, Sabha Bhatti, Zainab Samad, Mohamed A. Effat, Mark H. Eckman, and Tarek Helmy. “Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials.J Invasive Cardiol 21, no. 11 (November 2009): 589–95.
Hakeem A, Khan FM, Bhatti S, Samad Z, Effat MA, Eckman MH, et al. Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials. J Invasive Cardiol. 2009 Nov;21(11):589–95.
Hakeem, Abdul, et al. “Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials.J Invasive Cardiol, vol. 21, no. 11, Nov. 2009, pp. 589–95.
Hakeem A, Khan FM, Bhatti S, Samad Z, Effat MA, Eckman MH, Helmy T. Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials. J Invasive Cardiol. 2009 Nov;21(11):589–595.

Published In

J Invasive Cardiol

EISSN

1557-2501

Publication Date

November 2009

Volume

21

Issue

11

Start / End Page

589 / 595

Location

United States

Related Subject Headings

  • Stents
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Myocardial Infarction
  • Incidence
  • Humans
  • Coronary Restenosis
  • Coronary Artery Disease
  • Cardiovascular System & Hematology
  • Angioplasty, Balloon, Coronary